Press Releases

Newsroom
In the News
Press Releases
Resources for Journalists

Press Releases

Share
Share
and/or
516 News Releases found
Memorial Sloan Kettering Cancer Center Tops Prestigious List of Highly Cited Researchers 2022
Memorial Sloan Kettering Cancer Center Tops Prestigious List of Highly Cited Researchers 2022

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that it is ranked among the top 15 organizations with the greatest number of highly cited scientific researchers worldwide, according to the annual list of Highly Cited Researchers published by the Institute for Scientific Information at Clarivate.
A Fred's Team runner
Fred's Team Makes History by Raising $100 Million for Cancer Research

Fred’s Team, MSK’s running program, has made history by surpassing $100 million in total funds raised for cancer research.
Eli L. Diamond, MD and Omar Abdel-Wahab, MD
FDA Approves Oral MEK Inhibitor Cobimetinib for Histiocytic Neoplasms, Research Led by Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the oral MEK inhibitor drug cobimetinib (COTELLIC®) for the treatment of adult patients with the family of blood diseases know as histiocytic neoplasms (HN). These diseases include: Erdheim-Chester Disease, Rosai-Dorfman, and Langerhans Histiocytosis. Cobimetinib is an oral inhibitor of MEK1 and MEK2 currently approved to treat melanoma.
MSK Awards & Appointments October 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:
Carol Morris, MD, MS
Carol Morris Named Chief of the Orthopaedic Surgery Service at Memorial Sloan Kettering Cancer Center

Carol Morris, MD, MS, has assumed the position of Chief of the Orthopaedic Surgery Service at Memorial Sloan Kettering Cancer Center (MSK).
Left to right: Eileen M. O'Reilly, MD, Christine A. Iacobuzio-Donahue, MD, PhD
Memorial Sloan Kettering Cancer Center Receives NCI SPORE Grant to Improve Outcomes for Patients with Pancreatic Cancer

Memorial Sloan Kettering Cancer Center (MSK) today announced that it has been awarded a Specialized Programs of Research Excellence (SPORE) grant for pancreatic research by the National Cancer Institute (NCI).
Sloan Kettering Institute’s Alexander Gitlin
Sloan Kettering Institute’s Alexander Gitlin Honored with Prestigious NIH Director’s Early Independence Award

Sloan Kettering Institute’s (SKI) Alexander Gitlin, MD, PhD of Memorial Sloan Kettering Cancer Center (MSK) was recognized as a winner of the National Institutes of Health (NIH) Director’s Early Independence Award.
MSK Awards & Appointments September 2022

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:
CAR T-Cell Therapy Proves Effective in First Trial in Patients with Resistant Multiple Myeloma

A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan Kettering Cancer Center (MSK), Dana-Farber Cancer Institute, and Roswell Park Comprehensive Cancer Center report in a new study.
Memorial Sloan Kettering Cancer Center Creates Innovative Telemedicine Platform to Provide Patients Greater Access to Care

Memorial Sloan Kettering Cancer Center (MSK) is marking a year since the launch of MSK Telemedicine – an online solution for remote care that has been ...